drugset / Trial / NCT00945425

AZD7325 Japan Multiple Ascending Dose (MAD) Study

NCT00945425

Phase 1 Terminated 48 enrolled AstraZeneca
RandomizedSingle-groupQuadruple-blindBasic science

Summary

The purpose of this study is to evaluate the safety and tolerability after repeated ascending doses of AZD7325 in Japanese healthy male subjects.

Timeline

Start
2009-07
Primary completion
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7325 Small molecule Oral

Indications

No indication recorded.